On the verge of the 2001 recession, in February 2001, the real-time
data showed GDP growth declining to 1.1% (green line). But with the Fed
cutting rates, the S&P 500 saw a one-and-a-half-month 19% spurt in
April-May, even as the recession tightened its grip.
And in November 2007, on the cusp of the Great Recession, real-time
data showed GDP growth surging to 4.9% (red line). Only in the years
following the recession did revisions cut it down to less than half that
initial reading.
The point is that, at least in real time, the strength of GDP growth
does not tell us whether a recession is about to hit. It is only long
after the fact, following repeated revisions, that the GDP data becomes
more informative about the timing of the recession.
While the current cycle’s recent 2.6% GDP growth print – tracking
right in-between the 2001 and 2007 trajectories – was well received by
many economic prognosticators (blue line), by no means does it rule out a
looming recession.
In principle, GDP is a coincident indicator of the economy, with no real predictive value. But because more than half of
the initial GDP estimate is based on survey data and the extrapolation
of recent trends, the initial vintages of GDP are often misleading,
especially around business cycle turning points.
This helps explain why it is often only well after a recession has
begun that revisions to GDP data show an economic contraction in
progress. Until then, the consensus may be wrongly persuaded that the
coast is clear.
This is a key reason why good leading indexes are so valuable. Unlike
GDP, ECRI’s leading indexes avoid major revisions over time, most
crucially with regard to their cyclical timing and directional calls.
Consequently, we were able to call the 2001 recession and Great
Recession on a timely basis.
多量のオピオイドを米国に送り込み、米国で深刻な麻薬中毒問題を引き起こしています。現代版「阿片戦争」です。あのトヨタ初の女性取締役もオピオイド中毒で逮捕解任されましたよね。 US Is Dependent On China For Almost 80% Of Its Medicine by Tyler Durden Fri, 05/31/2019 - 12:55 Experts are warning that the U.S. has become way too reliant on China for all our medicine , our pain killers, antibiotics, vitamins, aspirin and many cancer treatment medicine. 専門家はこう警告する、米国はすべての医薬品、痛み止め、抗生物質、ビタミン、アスピリン、各種抗がん剤で、中国依存度が高すぎる。 Fox Business reports that according to FDA estimates at least 80 percent of active ingredients found in all of America’s medicine come from abroad, primarily from China . And it’s not just the ingredients, China wants to become the world’s dominant generic drug maker. So far Chinese companies are making generic for everything from high blood pressure to chemotherapy drugs. 90 percent of America’s prescriptions a...
Amazonで買物をしてContrarianJを応援しよう Silver Outperforming Gold 2 Adam Hamilton July 26, 2019 3232 Words Silver has blasted higher in the last couple weeks, far outperforming gold. This is certainly noteworthy, as silver has stunk up the precious-metals joint for years. This deeply-out-of-favor metal may be embarking on a sea-change sentiment shift, finally returning to amplifying gold’s upside. Silver is not only radically undervalued relative to gold, but investors are aggressively buying. Silver’s upside potential is massive. ここ２週シルバーは急騰した、ゴールドを遥かに凌ぐものだ。これは注目すべきことだ、もう何年もシルバーはひどいものだった。この極端に嫌われた金属が大きく心理を買えている、とうとうゴールド上昇を増幅するに至った。シルバーは対ゴールドで極端に過小評価されているだけでなく、投資家は積極的に買い進んでいる。シルバーの潜在上昇力は巨大なものだ。 Silver’s performance in recent years has been brutally bad, repelling all but the most fanatical contrarians. Historically silver prices have been mostly ...
米国はよく理解してませんが、日本の場合では量的緩和で日銀が国債買い上げした資金は日銀当座預金にそのままです、市中には流れていません。でもNHKのニュース等では「ジャブジャブ」という表現をアナウンサーが使い、さらに丁寧に水道の蛇口からお金が吐き出される画像まで示してくれます。これって心理効果が大きいですよね。量的緩和とは何かを７時のニュースや新聞でこれ以上丁寧に解説するのはそう簡単ではありません。一般の人も株式をやっている人も「イメージ」で捉える以上はそう簡単にできません。多くの人は量的緩和とはなにか、を理解していないと私は想像しています。 ただし、国債を買い上げるので長期金利が低下し住宅ローン金利等が下がったのは確実な効果です。一方で長短金利差が少なくなると銀行のビジネスモデルが成り立たなくなりますが。 This Is The One Chart Every Trader Should Have "Taped To Their Screen" by Tyler Durden Sat, 01/19/2019 - 18:55 After a year of tapering, the Fed’s balance sheet finally captured the market’s attention during the last three months of 2018. 一年間のテーパリング後、FEDバランスシートがとうとう市場の注目をあびることになった、２０１８年の最後の３ヶ月だ。 By the start of the fourth quarter, the Fed had finished raising the caps on monthly roll-off of its balance sheet to the full $50bn per month (peaking at $30bn USTs, $20bn MBS...
